Appendix 4C Quarterly Report & Company Update
150422_Appendix 4C Quarterly Report & Company Update
Joint Patent with Japanese Corporation now published
150331_Joint Patent with Japanese Corporation now published
Final Patient in Cohort Demonstrates Tumour Marker Reduction
150324_Final Patient in Cohort Demonstrates Tumour Marker Reduction
Appendix 3B and s708 Notice
150320_Appendix 3B and s708 Notice
Completion of Lowest Dose Cohort in Human Cancer Trial
150317_Completion of Lowest Dose Cohort in Human Cancer Trial
PharmAust completes $3.14m Share Placement oversubscribed
150316_PharmAust completes $3.14m Share Placement oversubscribed
PharmAust Shareholder Presentation – March 2015
150319_PharmAust Shareholder Presentation – March 2015
Trading Halt
150312_Trading Halt
American Assoc for Cancer accepts Late-Breaking Abstract
[pdf-embedder url=”https://www.pharmaust.com/wp-content/uploads/2015/03/150306_American-Assoc-for-Cancer-accepts-Late-Breaking-Abstract.pdf” title=”150306_American Assoc for Cancer accepts Late-Breaking Abstract”
Human Trial Prelim Results Shows Reduction in Tumour Markers
150209_Human Trial Prelim Results Shows Reduction in Tumour Markers